1. Home
  2. XTLB vs KRKR Comparison

XTLB vs KRKR Comparison

Compare XTLB & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTLB
  • KRKR
  • Stock Information
  • Founded
  • XTLB 1993
  • KRKR 2010
  • Country
  • XTLB Israel
  • KRKR China
  • Employees
  • XTLB N/A
  • KRKR N/A
  • Industry
  • XTLB Biotechnology: Pharmaceutical Preparations
  • KRKR Business Services
  • Sector
  • XTLB Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • XTLB Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • XTLB 7.8M
  • KRKR 6.6M
  • IPO Year
  • XTLB 2005
  • KRKR 2019
  • Fundamental
  • Price
  • XTLB $1.76
  • KRKR $3.22
  • Analyst Decision
  • XTLB
  • KRKR
  • Analyst Count
  • XTLB 0
  • KRKR 0
  • Target Price
  • XTLB N/A
  • KRKR N/A
  • AVG Volume (30 Days)
  • XTLB 12.8K
  • KRKR 22.3K
  • Earning Date
  • XTLB 02-20-2025
  • KRKR 12-31-2024
  • Dividend Yield
  • XTLB N/A
  • KRKR N/A
  • EPS Growth
  • XTLB N/A
  • KRKR N/A
  • EPS
  • XTLB N/A
  • KRKR N/A
  • Revenue
  • XTLB N/A
  • KRKR $41,654,350.00
  • Revenue This Year
  • XTLB N/A
  • KRKR $45.99
  • Revenue Next Year
  • XTLB N/A
  • KRKR $31.46
  • P/E Ratio
  • XTLB N/A
  • KRKR N/A
  • Revenue Growth
  • XTLB N/A
  • KRKR N/A
  • 52 Week Low
  • XTLB $0.77
  • KRKR $2.76
  • 52 Week High
  • XTLB $4.99
  • KRKR $12.60
  • Technical
  • Relative Strength Index (RSI)
  • XTLB 50.14
  • KRKR 52.25
  • Support Level
  • XTLB $1.42
  • KRKR $3.10
  • Resistance Level
  • XTLB $1.83
  • KRKR $3.69
  • Average True Range (ATR)
  • XTLB 0.13
  • KRKR 0.35
  • MACD
  • XTLB -0.02
  • KRKR 0.06
  • Stochastic Oscillator
  • XTLB 53.13
  • KRKR 70.43

About XTLB XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: